These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 6442909)

  • 1. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
    Greer IA; Walker JJ; Calder AA; Forbes CD
    Thromb Res; 1985 Dec; 40(5):631-43. PubMed ID: 3937284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML; Jaffe EA
    Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation studies in whole human blood.
    Saniabadi AR; Lowe GD; Forbes CD; Prentice CR; Barbenel JC
    Thromb Res; 1983 Jun; 30(6):625-32. PubMed ID: 6412393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N; Sakaguchi K; Fujitani B; Aishita H
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical evaluation of platelet aggregation in whole human blood.
    Riess H; Braun G; Brehm G; Hiller E
    Am J Clin Pathol; 1986 Jan; 85(1):50-6. PubMed ID: 3079628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of prostacyclin in the separation from plasma and washing of human platelets.
    Vargas JR; Radomski M; Moncada S
    Prostaglandins; 1982 Jun; 23(6):929-45. PubMed ID: 6812168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter.
    Fox SC; Burgess-Wilson M; Heptinstall S; Mitchell JR
    Thromb Haemost; 1982 Dec; 48(3):327-9. PubMed ID: 6819649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: additional evidence for the role of ADP.
    Saniabadi AR; Lowe GD; Barbenel JC; Forbes CD
    Thromb Haemost; 1984 Feb; 51(1):115-8. PubMed ID: 6719381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
    Rao GH; Reddy KR; White JG
    Prostaglandins Med; 1980 Jun; 4(6):385-97. PubMed ID: 6251492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.